Aker BioMarine ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program

9 May 2023: Reference is made to Aker BioMarine ASA's (the "Company") stock exchange announcement earlier today regarding the offer of new shares to employees in the Company and its Norwegian subsidiaries (the "Employee Share Purchase Program") and the board of directors' resolution to increase the share capital of the Company. 

The following primary insiders of the Company have today, on 9 May 2023, applied for, been allocated and subscribed new shares in the Company at the offer price of NOK 29,81 per share in the Employee Share Purchase Program.

-	Matts Johansen, CEO, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Johansen controls 1,080,958 shares in the company.

-	Webjørn Barstad, EVP Offshore, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Barstad controls 14 904 shares in the company.

-	Tone Lorentzen, EVP Supply Chain, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Lorentzen controls 7 404 shares in the company.

-	Simon Seward, EVP Human Health & Nutrition, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Seward controls 2 904 shares in the company.

-	Trond Atle Smedsrud, EVP AKBM RAW, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Smedsrud controls 6 410 shares in the company.

-	Anniken Færgestad, VP Finance, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Færgestad controls 1 610 shares in the company.

-	Sindre Skjong, Board Director, has subscribed for 1 610 new shares in the Company for a total subscription amount of NOK 47 994. Following the subscription, Skjong controls 2 904 shares in the company.

Attached to this announcement is supplementary information regarding primary insiders’ share subscriptions.

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact
Katrine Klaveness, CFO
Mobile: +47 991 58 915
Email: Katrine.Klaveness@akerbiomarine.com

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.